Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Thai herbal recipes vs Favipiravir in asymptomatic or mild COVID-19
TCTR20211006004Phase 2Not yet recruiting
- Sponsor
- Giving Mind Nirvana Soul Foundation
- Start
- Oct 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of favipiravir in coronavirus disease 2019 (COVID-19), sponsored by Giving Mind Nirvana Soul Foundation. Planned start Oct 2021; status: not yet recruiting.
02
Drugs
favipiravir
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on TCTR20211006004.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20211006004.